Despite an effective vaccine, measles remains a major health problem globally, particularly in developing countries. More than 30% of children show primary... ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2012
• September 2012

Deborah Lehmann D AO, MBBS, MSc Honorary Emeritus Fellow Honorary Emeritus Fellow Authors: Jayasinghe S, Chiu C, Menzies R, Lehmann D, Cook H, Giele C, et al. Authors notes:  Vaccine. 2015;33(48):6666-74. Keywords: Pneumococcal disease, Pneumococcal ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2010
• September 2010

In 2019, the World Health Organization (WHO) flagged vaccine hesitancy as one of the top 10 threats to global health. The drivers of and barriers to under-vaccination include logistics (access to and awareness of affordable vaccines), as well as a complex mix of psychological, social, political, and cultural factors. ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2021
• February 2021

This paper reports on the shift in parental attitude to vaccination after 2010, due to an unprecedented increase in febrile reactions in children receiving... ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2014
• May 2014

We assessed replication and excretion of the live attenuated CYD-TDV into biological fluids following vaccination in dengue-naive adults in Australia. ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2017
• October 2017

Anthony Jonathan Tim Kicic Carapetis AM Barnett A JR TB BSc (Hons) PhD AM MBBS FRACP FAFPHM PhD FAHMS PhD Rothwell Family Fellow; Head, Airway Epithelial Research Executive Director; Head, Strep A Translation; Co-Founder of REACH Head of the Strep A ...

• 1. Telethon Kids Institute
• Projects

Christopher Jennifer Peter Blyth Kent Richmond CC J PC MBBS (Hons) DCH FRACP FRCPA PhD RN MBBS MRCP(UK) FRACP Director, Wesfarmers Centre of Vaccines and Infectious Diseases; Co-Head, Infectious Diseases Epidemiology, Wesfarmers Centre of Vaccines ...

• 1. Telethon Kids Institute
• Projects

The ability for vaccines to protect against infectious diseases varies among individuals, but computational models employed to inform policy typically do not account for this variation. Here we examine this issue: we implement a model of vaccine efficacy developed in the context of SARS-CoV-2 in order to evaluate the general implications of modelling correlates of protection on the individual level. ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2023
• October 2023

Since the emergence of SARS-CoV-2 in 2019 through to mid-2021, much of the Australian population lived in a COVID-19-free environment. This followed the broadly successful implementation of a strong suppression strategy, including international border closures. With the availability of COVID-19 vaccines in early 2021, the national government sought to transition from a state of minimal incidence and strong suppression activities to one of high vaccine coverage and reduced restrictions but with still-manageable transmission. ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2023
• August 2023

Empyema is a serious complication of pneumonia frequently caused by Streptococcus pneumoniae (SP). We assessed the impact of the 13-valent pneumococcal conjugate vaccine (13vPCV) on childhood pneumonia and empyema after inclusion in the Australian National Immunisation Program. ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2021
• January 2021

A biologically active vaccine may produce a low measured vaccine efficacy under a range of epidemiological, vaccine-related and logistical conditions ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2018
• May 2018

To identify and describe potentially vaccine-preventable child deaths in New South Wales (NSW). ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2018
• April 2018